Camber Pharmaceuticals recalls 87 lots of Losartan on NDEA

The blood pressure river and recalled heart medications continued to flow on Thursday while Camber Pharmaceuticals announced the recall of 87 lots of Losartan potassium for too much NDEA analysis.

While NDEA (N-nitrosodiethylamine) is naturally present in some foods and in drinking water, it is classified as a probable human carcinogen by the International Agency for Research on Cancer. Its presence in the active substance of these drugs, manufactured in this case by Hetero Labs Limited, based in India, is considered an impurity.

Hetero Labs Limited also manufactured the active ingredient in Losartan's unique lot that Macleods Pharmaceuticals Limited recalled last week for having too much NDEA.

The Camber booster is superior to that of Macleods because it consists of tablets of different sizes (25 mg, 50 mg, 100 mg) in different bottle sizes (30, 90, 500 and 1000 bottles). The full list is available at the company's reminder announcement Thursday afternoon.

As in previous reminders of Losartan, Valsartan or Irbesartan, it is advisable for those who take the recalled medicine to continue taking it until a doctor prescribes another treatment. Although the FDA has limitations on what is acceptable for the daily intake of NDEA, it has also admitted that the chances of getting cancer as a result of an excess of drugs in your medicine are low.

Consumers with questions may call Camber at 1-866-495-1995 Monday to Friday, 9 am to 5 pm Eastern Time.